Novo Nordisk Up 6.5% Since Goldman Sachs Downgraded One Week Ago (NVO)
July 06, 2016 at 01:14 AM EDT
One week ago Novo Nordisk (NYSE:NVO) was downgraded from Conviction Buy to Buy at Goldman Sachs. Novo Nordisk shares are selling at $54.23, 6.5% above the $50.91 price point...
